Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

PURPOSE: The Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial included a prospectively planned pathology substudy testing the predictive value of progesterone receptor (PgR) expression for outcome of estrogen receptor–positive (ER-positive) early breast cancer treated with exemestane ver...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bartlett, John M.S., Brookes, Cassandra L., Robson, Tammy, van de Velde, Cornelis J.H., Billingham, Lucinda J., Campbell, Fiona M., Grant, Margaret, Hasenburg, Annette, Hille, Elysée T.M., Kay, Charlene, Kieback, Dirk G., Putter, Hein, Markopoulos, Christos, Kranenbarg, Elma Meershoek-Klein, Mallon, Elizabeth A., Dirix, Luc, Seynaeve, Caroline, Rea, Daniel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2011
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082973/
https://ncbi.nlm.nih.gov/pubmed/21422407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3677
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia